HPS Pharmacies wishes to advise that Sanofi-Aventis is discontinuing Vivaxim® as follows:

Vivaxim® Injection Syringe
Hepatitis a virus antigen + Salmonella typhi Vi polysaccharide
ARTG 82745

This product will no longer be supplied in Australia once the current stocks have been depleted. The last batches manufactured have an expiry date of 30 November 2024.

Single antigen vaccines that may be considered as alternatives include:

  • Avaxim® (inactivated hepatitis A vaccine);
  • Havrix® 1440 (inactivated hepatitis A vaccine);
  • Havrix® Junior (inactivated hepatitis A vaccine);
  • Vaqta® (inactivated hepatitis A vaccine);
  • Typhim Vi® (salmonella typhi vi polysaccharide vaccine); and
  • Vivotif® Oral (oral typhoid vaccine).

Individual product information documents should be consulted for information on indications and administration instructions.

Sanofi-Aventis also anticipates that Avaxim® may experience a supply shortage during April and May 2024.

Retain this notice in a prominent position, including in other related business units for at least one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Sanofi-Aventis on 1800 829 468 or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates